277 related articles for article (PubMed ID: 35129856)
1. Comprehensive analysis of PTEN-related ceRNA network revealing the key pathways WDFY3-AS2 - miR-21-5p/miR-221-3p/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Zhou X; Liu G; Xu M; Ying X; Li B; Cao F; Cheng S; Xiao B; Cheng M; Liang L; Jia M; Li W; Liu J; Li Z
Mol Carcinog; 2022 May; 61(5):508-523. PubMed ID: 35129856
[TBL] [Abstract][Full Text] [Related]
2. LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis.
Zhang Q; Guan F; Fan T; Li S; Ma S; Zhang Y; Guo W; Liu H
J Cell Mol Med; 2020 Jul; 24(14):8206-8220. PubMed ID: 32536038
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
Li W; Ma S; Bai X; Pan W; Ai L; Tan W
J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
[TBL] [Abstract][Full Text] [Related]
4. WDFY3-AS2: A Potential Prognostic Factor and Therapeutic Target Related to Cancer.
Mou J; Chen J; Wu Y; He Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2814-2821. PubMed ID: 36093824
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
6. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
7. The hsa-miR-3613-5p, a potential oncogene correlated with diagnostic and prognostic merits in kidney renal clear cell carcinoma.
Ahmadi M; Najari-Hanjani P; Ghaffarnia R; Ghaderian SMH; Mousavi P; Ghafouri-Fard S
Pathol Res Pract; 2023 Nov; 251():154903. PubMed ID: 37879147
[TBL] [Abstract][Full Text] [Related]
8. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
Ye Y; Zhang F; Chen Q; Huang Z; Li M
Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network.
Gong K; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
PLoS One; 2021; 16(6):e0252452. PubMed ID: 34101736
[TBL] [Abstract][Full Text] [Related]
11. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
Liu S; Yu Y; Wang Y; Zhu B; Han B
Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
[TBL] [Abstract][Full Text] [Related]
12. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma.
Huang M; Zhang T; Yao ZY; Xing C; Wu Q; Liu YW; Xing XL
BMC Med Genomics; 2021 Mar; 14(1):72. PubMed ID: 33750388
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of HOXA-AS2 inhibits inflammation and apoptosis in podocytes via sponging miRNA-302b-3p to upregulate TIMP3.
Li X; Yu HM
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4963-4970. PubMed ID: 32432759
[TBL] [Abstract][Full Text] [Related]
16. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
Liu J; Chen M; Ma L; Dang X; Du G
Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA WDFY3-AS2 Represses the Progression of Esophageal Cancer through miR-18a/PTEN Axis.
Kong Q; Li G; Yin G; Li K; Zhang D; Xu W
J Oncol; 2021; 2021():9951010. PubMed ID: 34194502
[TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
20. WT1-AS/IGF2BP2 Axis Is a Potential Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma According to ceRNA Network Comprehensive Analysis Combined with Experiments.
Jia M; Shi Y; Xie Y; Li W; Deng J; Fu D; Bai J; Ma Y; Zuberi Z; Li J; Li Z
Cells; 2021 Dec; 11(1):. PubMed ID: 35011587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
